Prolonged disorders of consciousness: A response to a "critical evaluation of the new UK guidelines."


Journal

Clinical rehabilitation
ISSN: 1477-0873
Titre abrégé: Clin Rehabil
Pays: England
ID NLM: 8802181

Informations de publication

Date de publication:
Sep 2022
Historique:
pubmed: 14 5 2022
medline: 5 8 2022
entrez: 13 5 2022
Statut: ppublish

Résumé

In 2020, The London Royal College of Physicians published "Prolonged disorders of consciousness following sudden-onset brain injury: national clinical guidelines". In 2021, in the journal Brain, Scolding et al. published "a critical evaluation of the new UK guidelines". This evaluation focussed on one of the 73 recommendations in the National Clinical Guidelines. They also alleged that the guidelines were unethical. They criticised our recommendation not to use activation protocols using fMRI, electroencephalography, or Positron Emission Tomography. They claim these tests can (a) detect 'covert consciousness', (b) add predictive value and (c) should be part of routine clinical care. They also suggest that our guideline was driven by cost considerations, leading to clinicians deciding to withdraw treatment at 72 h. Our detailed review of the evidence confirms the American Academy of Neurology Practise Guideline (2018) and the European Academy of Neurology Guideline (2020), which agree that insufficient evidence supports their approach. The ethical objections are based on unwarranted assumptions. Our guideline does not make any recommendations about management until at least four weeks have passed. We explicitly recommend that expert assessors undertake ongoing surveillance and monitoring; we do not suggest that patients be abandoned. Our recommendation will increase the cost We had ethicists in the working party. We conclude the "critical evaluation" fails to provide evidence for their criticism and that the ethical objections arise from incorrect assumptions and unsupported interpretations of evidence and our guideline. The 2020 UK national guidelines remain valid.

Sections du résumé

BACKGROUND BACKGROUND
In 2020, The London Royal College of Physicians published "Prolonged disorders of consciousness following sudden-onset brain injury: national clinical guidelines". In 2021, in the journal Brain, Scolding et al. published "a critical evaluation of the new UK guidelines". This evaluation focussed on one of the 73 recommendations in the National Clinical Guidelines. They also alleged that the guidelines were unethical.
CRITICISMS UNASSIGNED
They criticised our recommendation not to use activation protocols using fMRI, electroencephalography, or Positron Emission Tomography. They claim these tests can (a) detect 'covert consciousness', (b) add predictive value and (c) should be part of routine clinical care. They also suggest that our guideline was driven by cost considerations, leading to clinicians deciding to withdraw treatment at 72 h.
EVIDENCE METHODS
Our detailed review of the evidence confirms the American Academy of Neurology Practise Guideline (2018) and the European Academy of Neurology Guideline (2020), which agree that insufficient evidence supports their approach.
ETHICS METHODS
The ethical objections are based on unwarranted assumptions. Our guideline does not make any recommendations about management until at least four weeks have passed. We explicitly recommend that expert assessors undertake ongoing surveillance and monitoring; we do not suggest that patients be abandoned. Our recommendation will increase the cost We had ethicists in the working party.
CONCLUSION CONCLUSIONS
We conclude the "critical evaluation" fails to provide evidence for their criticism and that the ethical objections arise from incorrect assumptions and unsupported interpretations of evidence and our guideline. The 2020 UK national guidelines remain valid.

Identifiants

pubmed: 35546561
doi: 10.1177/02692155221099704
pmc: PMC9354059
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1267-1275

Références

N Engl J Med. 2019 Jun 27;380(26):2497-2505
pubmed: 31242361
Front Neurol. 2017 Dec 18;8:688
pubmed: 29326648
PLoS Med. 2007 Oct 16;4(10):e296
pubmed: 17941714
Lancet. 2014 Aug 9;384(9942):514-22
pubmed: 24746174
Brain. 2014 Aug;137(Pt 8):2258-70
pubmed: 24919971
IEEE Trans Neural Syst Rehabil Eng. 2003 Jun;11(2):145-7
pubmed: 12899258
Eur J Neurol. 2018 Apr;25(4):619-625
pubmed: 29338107
Brain. 2021 Jul 28;144(6):1655-1660
pubmed: 33778883
Neurology. 2002 Feb 12;58(3):349-53
pubmed: 11839831
Neuropsychol Rehabil. 2018 Dec;28(8):1254-1265
pubmed: 28762872
Neurology. 2018 Sep 4;91(10):450-460
pubmed: 30089618
Brain. 2017 Sep 1;140(9):2399-2414
pubmed: 29050383
BMJ. 2015 Oct 28;351:h5527
pubmed: 26511519
PLoS One. 2013 Nov 22;8(11):e80886
pubmed: 24278339
Brain. 2018 May 1;141(5):1404-1421
pubmed: 29562312
J Neurol. 2012 Jun;259(6):1087-98
pubmed: 22081100
J Neurol Neurosurg Psychiatry. 2016 May;87(5):485-92
pubmed: 26139551
J Med Ethics. 2017 Jul;43(7):457-458
pubmed: 27501786
Mayo Clin Proc. 2006 Sep;81(9):1155-8
pubmed: 16970211
Brain. 2020 Apr 1;143(4):1177-1189
pubmed: 32101603
PLoS One. 2014 Apr 14;9(4):e95082
pubmed: 24733575
Lancet. 2011 Dec 17;378(9809):2088-94
pubmed: 22078855
Eur J Neurol. 2020 May;27(5):741-756
pubmed: 32090418
Clin Med (Lond). 2008 Oct;8(5):502-7
pubmed: 18975482
Methods. 2008 Aug;45(4):336-41
pubmed: 18762138
Neuroimage Clin. 2021;30:102601
pubmed: 33652375
N Engl J Med. 2010 Feb 18;362(7):579-89
pubmed: 20130250
BMJ. 2008 May 3;336(7651):995-8
pubmed: 18456631
Science. 2006 Sep 8;313(5792):1402
pubmed: 16959998

Auteurs

Derick T Wade (DT)

6395Oxford Brookes University, Oxford, UK.

Lynne Turner-Stokes (L)

Cicely Saunders Institute, 4616King's College London, London, UK.

E Diane Playford (ED)

Warwick Medical School, 2707University of Warwick, Coventry, UK.

Judith Allanson (J)

Department of Neurological Rehabilitation, 405352Addenbrookes Hospital, Cambridge, UK.

John Pickard (J)

Academic Neurosurgery, Department of Clinical Neurosciences, 406021University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH